Nederlof Michel
Keine laufenden Positionen mehr
Karriereverlauf von Nederlof Michel
Ehemalige bekannte Positionen von Nederlof Michel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Technik-/Wissenschafts-/F&E-Leiter | 16.06.2011 | - |
| Gründer | 15.06.2011 | - | |
| Präsident | 16.06.2011 | - |
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| President | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cernostics, Inc.
Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
- Börse
- Insiders
- Nederlof Michel
- Erfahrung
